ASTRAZENECA PHARMA INDIA LTD. - Astrazeneca Pharma India Limited Has Received An Import And Market Permission In Form CT-20 (Subsequent New Drug Approval) From The Central Drugs Standard Control Organisation, Directorate General Of Health Services, Government Of India For Dapagliflozin (Forxiga??) Tablets Of 10 Mg - Additional/ Extended Indication
25 Nov 2022
Please find the enclosed letter of the Company in relation to the captioned subject for your reference.
Source:
BSE India